Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

BENZONATATE CAPSULES

Active
SPE2DP-26-T-4467Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

BENZONATATE CAPSULES, USP, 100 MG, are supplied in bottles of 100 capsules each, with the active ingredient being 100 milligrams of benzonatate per capsule. The product is regulated by the FDA and must be stored at controlled room temperature between 20°C to 25°C (68°F to 77°F), protected from light, moisture, and humidity. It has a non-extendable shelf life of 36 months and must be marked in compliance with the latest Medical Marking Standard No. 1. Packaging must adhere to DLA’s RP001 requirements, MIL-STD-129 labeling standards, and either ASTM D3951 for non-hazardous items or TQ requirement IP025 if classified as hazardous under FED-STD-313. The unit of issue is a bottle (BT), and palletization must conform to DLA procurement standards. The item is identified by NSN 6505006601798 and has approved manufacturers including AVKARE LLC, GOLDEN STATE MEDICAL SUPPLY, INC., and PROFICIENT RX LP, each with their respective NDC numbers. This contract, issued under solicitation SPE2DP-26-T-4467, calls for two bottles to be delivered FOB destination within 10 days of award, with strict zero variance tolerance on quantity. Delivery is required to the U.S. military facility at Smith Barracks in Baumholder, Germany, with specified transportation and marking instructions governed by DLA procedural notes C19 and C20. The contract specifies the original required delivery date as August 5, 2026, and includes technical and quality requirements referenced from the DLA Master List, which take precedence over general commercial standards. The procurement is a federal acquisition under NAICS code 325412, with primary point of contact Imerah Burnett at the Department of Defense’s Medical Supply Chain PHARM FSA. All supplies must be marked with government identification only after acceptance, per RQ011, and the contracting official must submit an electronic referral in EBS prior to award.

General Info

100 mg benzonatate capsules, 2 bottles FOB Baumholder Germany by August 5, 2026, per DLA and FDA standards.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4467.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS

Full Description

Show more
BENZONATATE CAPSULES
BENZONATATE CAPSULES,USP, 100 MG, 100'S. 100 MILLIGRAMS OF BENZONATATE
ACTIVE INGREDIENT.UNIT OF ISSUE: BOTTLE (BT) OF 100ea. The capsules should be protected from light, moisture and humidity, and stored at controlled room temperature 20° to 25°C (68° to 77°F).
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
AVKARE LLC 4QGW8 P/N NDC42291-0091-01 GOLDEN STATE MEDICAL SUPPLY, INC. 1HT23 P/N NDC60429-0927-01 PROFICIENT RX LP 7GU24 P/N NDC71205-0885-00
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017715314 0001 BT 2.000
NSN/MATERIAL:6505006601798
SPE2DP-26-T-4467
SECTION B
PR: 7017715314 PRLI: 0001 CONT’D
DELIVERY (IN DAYS):0010
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
WK4GA8
0240 QM CO QM SUPPORT CO (
AWCF SSF SMITH BARRACKS BLDG 8338
AULENBACHER STRASSE
BAUMHOLDER 55774
DE
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
WK4GA8
0240 QM CO QM SUPPORT CO (
AWCF SSF SMITH BARRACKS BLDG 8338
AULENBACHER STRASSE
BAUMHOLDER 55774
DE
MARKFOR
WK4GA8
0240 QM CO QM SUPPORT CO (
AWCF SSF SMITH BARRACKS BLDG 8338
AULENBACHER STRASSE
BAUMHOLDER 55774
DE
M/F: (TCN) WK4GA862120040
RDD: 220
PROJ: 9GU TP 3
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
SPE2DP-26-T-4467
SECTION B
PR: 7017715314 PRLI: 0001 CONT’D
DIC: A01 DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:08/05/2026
SPE2DP-26-T-4467 NSN/Part Number: 6505-00-660-1798 Quantity: 2 BT Purchase Request: 7017715314QTY: 2 Delivery: 10 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
SLED
Supply of Gamma-Irradiated Colilert Reagents for Water TestingThe contract seeks the manufacture and supply of EPA-approved, gamma-irradiated Colilert reagents specifically designed for presence/absence testing of total coliform and E. coli in drinking water, ensuring compliance with federal safety standards for municipal water systems. The reagents must be produced under strict quality controls to maintain efficacy and consistency, with gamma irradiation serving as a critical step to ensure sterility and eliminate microbial contamination prior to use in field testing environments. Delivery schedules, packaging requirements, and documentation for regulatory compliance will be essential components of the supplier’s obligations. This is a subcontract opportunity posted by the Mississippi Department of Health under NAICS code 325412, which pertains to pharmaceutical and medicine manufacturing. Responses are due by August 24, 2026, and the work is intended to support state-level water quality monitoring programs across Mississippi. While specific quantities and delivery timelines are not detailed in the provided data, the supplier must be prepared to meet consistent demand for a testing reagent that is critical to public health protection. The contract does not designate a set-aside classification and requires adherence to all applicable EPA and state regulations governing water testing reagents.
MS DEPT of HEALTH

POSTED

about 19 hours ago

DEADLINE

in 20 days
View Details
NAICS: 325412
New
DIBBS
GABAPENTIN CAPSULES
Solicitation # SPE2DP-26-T-4457
GABAPENTIN CAPSULES, 100 MG in units of 100s, are procured under solicitation SPE2DP-26-T-4457 with a total requirement of 7,000 capsules across two line items, each with a 0% quantity variance. The item is regulated by the FDA and must comply with the DLA Master List of Technical and Quality Requirements, including shelf-life specifications of 36 months non-extendable for TYPE I (CODE Q) items. Packaging must meet Commercial standards and Medical Marking Standard No. 1, superseding MIL-STD-129, with all labeling and palletization aligned to RP001 and DLA packaging directives. Storage must maintain 25°C (77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F) per USP Controlled Room Temperature. The material is not classified as hazardous under FED-STD-313 and must be commercially packaged in accordance with ASTM D3951, though DLA requirements override any conflicting standards. Delivery is FOB destination with a five-day lead time and inspection and acceptance occurring at the destination point. The items are to be shipped via traceable means, not parcel post, to the USS MAKIN ISLAND LHD 8 at FPO AP 96672, with a required delivery date of April 3, 2026. Manufacturers include MARLEX PHARMACEUTICALS INC, CIPLA USA INC, and SCIEGEN PHARMACEUTICALS INC, identified by their respective NDC codes. The unit of issue is BT (100s), with each unit pack containing one BT. All packaging and marking must reflect the correct NSN 6505013871892, and vendors must use the DLA VSM system for shipment tracking. Government use codes and contract identifiers are specified for administrative and logistical tracking, and all documentation must adhere to the latest DLA procedural notes for transportation, marking, and delivery verification.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 541611
New
DIBBS
Small Business Subcontracting & Representation SupportThe contract seeks administrative and compliance support services focused on small business program representations, joint ventures, and certifications in alignment with Federal Acquisition Regulation and Department of Defense requirements. The work involves ensuring accurate and timely documentation and adherence to regulatory standards for small business classifications, subcontracting plans, and representation filings, with an emphasis on maintaining compliance across all phases of federal contracting processes. This support is critical for enabling eligible entities to properly declare and maintain their status under applicable small business programs and to facilitate valid joint venture arrangements. Performance will be centered in Gastonia, North Carolina, with a NAICS code of 541611 indicating management consulting services, suggesting a need for advisory and operational assistance rather than direct procurement or logistics. The solicitation was posted on August 3, 2026, with a response deadline of August 10, 2026, indicating a tight turnaround for proposals. Although no set-asides are specified, the nature of the services implies that eligibility and capability in navigating small business compliance frameworks will be central to evaluation. The contract falls under the Department of Defense, administered by the Medical Supply Chain Pharm FSA, requiring the contractor to work within the unique regulatory and procedural environment of military medical supply chain operations.
Administrative Management and General Management Consulting Services

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details